title: Ondansetron for prevention of intrathecal opioids-induced pruritus, nausea and vomiting after cesarean delivery.
authors.affiliation: Department of Anesthesiology Faculty of Medicine Chulalongkorn University King Chulalongkorn Memorial Hospital Pathumwan, Bangkok Thailand.
authors.forename: Somrat
authors.initials: S
authors.lastname: Charuluxananan
authors.forename: Oranuch
authors.initials: O
authors.lastname: Kyokong
authors.forename: Wanna
authors.initials: W
authors.lastname: Somboonviboon
authors.forename: Arunchai
authors.initials: A
authors.lastname: Narasethakamol
authors.forename: Pissamai
authors.initials: P
authors.lastname: Promlok
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000009:adverse effects*; D000932:Antiemetics / Q000627:therapeutic use*; D002585:Cesarean Section; D005260:Female; D006801:Humans; D009020:Morphine / Q000009:adverse effects; D017294:Ondansetron / Q000627:therapeutic use*; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D011247:Pregnancy; D011537:Pruritus / Q000139:chemically induced* / Q000517:prevention & control*; D017409:Sufentanil / Q000009:adverse effects
chemical_list: D000701:Analgesics, Opioid; D000932:Antiemetics; D017294:Ondansetron; D009020:Morphine; D017409:Sufentanil